160 related articles for article (PubMed ID: 37630714)
1. Glycemic Variability in Patients with Type 2 Diabetes Mellitus (T2DM): The Role of Melatonin in a Crossover, Double-Blind, Placebo-Controlled, Randomized Study.
Martorina W; Tavares A
Nutrients; 2023 Aug; 15(16):. PubMed ID: 37630714
[TBL] [Abstract][Full Text] [Related]
2. Effects of Melatonin on Glycemic Variability in Type 2 Diabetes Mellitus: Protocol for a Crossover, Double-Blind, Placebo-Controlled Trial.
Martorina W; Tavares A
JMIR Res Protoc; 2023 Aug; 12():e47887. PubMed ID: 37410852
[TBL] [Abstract][Full Text] [Related]
3. Effect of Acarbose on Glycemic Variability in Patients with Poorly Controlled Type 2 Diabetes Mellitus Receiving Stable Background Therapy: A Placebo-Controlled Trial.
Derosa G; Franzetti I; Querci F; D'Angelo A; Maffioli P
Pharmacotherapy; 2015 Nov; 35(11):983-90. PubMed ID: 26598090
[TBL] [Abstract][Full Text] [Related]
4. Consumption of melatonin supplement improves cardiovascular disease risk factors and anthropometric indices in type 2 diabetes mellitus patients: a double-blind, randomized, placebo-controlled trial.
Bazyar H; Zare Javid A; Bavi Behbahani H; Moradi F; Moradi Poode B; Amiri P
Trials; 2021 Mar; 22(1):231. PubMed ID: 33766084
[TBL] [Abstract][Full Text] [Related]
5. The effects of melatonin supplementation in adjunct with non-surgical periodontal therapy on periodontal status, serum melatonin and inflammatory markers in type 2 diabetes mellitus patients with chronic periodontitis: a double-blind, placebo-controlled trial.
Bazyar H; Gholinezhad H; Moradi L; Salehi P; Abadi F; Ravanbakhsh M; Zare Javid A
Inflammopharmacology; 2019 Feb; 27(1):67-76. PubMed ID: 30328031
[TBL] [Abstract][Full Text] [Related]
6. Effects of lixisenatide once daily on gastric emptying in type 2 diabetes--relationship to postprandial glycemia.
Lorenz M; Pfeiffer C; Steinsträsser A; Becker RH; Rütten H; Ruus P; Horowitz M
Regul Pept; 2013 Aug; 185():1-8. PubMed ID: 23665027
[TBL] [Abstract][Full Text] [Related]
7. Effects of melatonin and zinc on glycemic control in type 2 diabetic patients poorly controlled with metformin.
Hussain SA; Khadim HM; Khalaf BH; Ismail SH; Hussein KI; Sahib AS
Saudi Med J; 2006 Oct; 27(10):1483-8. PubMed ID: 17013468
[TBL] [Abstract][Full Text] [Related]
8. The Effects of Melatonin Supplementation on Parameters of Mental Health, Glycemic Control, Markers of Cardiometabolic Risk, and Oxidative Stress in Diabetic Hemodialysis Patients: A Randomized, Double-Blind, Placebo-Controlled Trial.
Ostadmohammadi V; Soleimani A; Bahmani F; Aghadavod E; Ramezani R; Reiter RJ; Mansournia MA; Banikazemi Z; Soleimani M; Zaroudi M; Asemi Z
J Ren Nutr; 2020 May; 30(3):242-250. PubMed ID: 31597622
[TBL] [Abstract][Full Text] [Related]
9. Effect of Dapagliflozin as an Add-on Therapy to Insulin on the Glycemic Variability in Subjects with Type 2 Diabetes Mellitus (DIVE): A Multicenter, Placebo-Controlled, Double-Blind, Randomized Study.
Lee SH; Min KW; Lee BW; Jeong IK; Yoo SJ; Kwon HS; Choi YH; Yoon KH
Diabetes Metab J; 2021 May; 45(3):339-348. PubMed ID: 32602273
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetic, pharmacodynamic, and tolerability profiles of the dipeptidyl peptidase-4 inhibitor linagliptin: a 4-week multicenter, randomized, double-blind, placebo-controlled phase IIa study in Japanese type 2 diabetes patients.
Horie Y; Kanada S; Watada H; Sarashina A; Taniguchi A; Hayashi N; Graefe-Mody EU; Woerle HJ; Dugi KA
Clin Ther; 2011 Jul; 33(7):973-89. PubMed ID: 21723606
[TBL] [Abstract][Full Text] [Related]
11. Melatonin administration lowers biomarkers of oxidative stress and cardio-metabolic risk in type 2 diabetic patients with coronary heart disease: A randomized, double-blind, placebo-controlled trial.
Raygan F; Ostadmohammadi V; Bahmani F; Reiter RJ; Asemi Z
Clin Nutr; 2019 Feb; 38(1):191-196. PubMed ID: 29275919
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of linagliptin in subjects with long-standing type 2 diabetes mellitus (>10 years): evidence from pooled data of randomized, double-blind, placebo-controlled, phase III trials.
Lajara R; Aguilar R; Hehnke U; Woerle HJ; von Eynatten M
Clin Ther; 2014 Nov; 36(11):1595-605. PubMed ID: 25236917
[TBL] [Abstract][Full Text] [Related]
13. Effect of bromocriptine-QR therapy on glycemic control in subjects with type 2 diabetes mellitus whose dysglycemia is inadequately controlled on insulin.
Chamarthi B; Cincotta AH
Postgrad Med; 2017 May; 129(4):446-455. PubMed ID: 28374645
[TBL] [Abstract][Full Text] [Related]
14. β-Lactoglobulin Elevates Insulin and Glucagon Concentrations Compared with Whey Protein-A Randomized Double-Blinded Crossover Trial in Patients with Type Two Diabetes Mellitus.
Smedegaard SB; Mose M; Hulman A; Mikkelsen UR; Møller N; Wegener G; Jessen N; Rittig N
Nutrients; 2021 Jan; 13(2):. PubMed ID: 33499025
[TBL] [Abstract][Full Text] [Related]
15. Comparison of Glycemic Excursion Using Flash Continuous Glucose Monitoring in Patients with Type 2 Diabetes Mellitus Before and After Treatment with Voglibose.
Kasthuri S; Poongothai S; Anjana RM; Selvakumar J; Muthukumar S; Kayalvizhi S; Tariq S; Honey E; Gupta PK; Venkatesan U; Mohan V
Diabetes Technol Ther; 2021 Mar; 23(3):213-220. PubMed ID: 32916063
[No Abstract] [Full Text] [Related]
16. Effects of melatonin supplementation in patients with type 2 diabetes mellitus and chronic periodontitis under nonsurgical periodontal therapy: A double-blind randomized controlled trial.
Bazyar H; Zare Javid A; Zakerkish M; Yousefimanesh HA; Haghighi-Zadeh MH
J Res Med Sci; 2022; 27():52. PubMed ID: 36092489
[TBL] [Abstract][Full Text] [Related]
17. Effect of exenatide on 24-hour blood glucose profile compared with placebo in patients with type 2 diabetes: a randomized, double-blind, two-arm, parallel-group, placebo-controlled, 2-week study.
Schwartz SL; Ratner RE; Kim DD; Qu Y; Fechner LL; Lenox SM; Holcombe JH
Clin Ther; 2008 May; 30(5):858-67. PubMed ID: 18555933
[TBL] [Abstract][Full Text] [Related]
18. Effects of personalized diets by prediction of glycemic responses on glycemic control and metabolic health in newly diagnosed T2DM: a randomized dietary intervention pilot trial.
Rein M; Ben-Yacov O; Godneva A; Shilo S; Zmora N; Kolobkov D; Cohen-Dolev N; Wolf BC; Kosower N; Lotan-Pompan M; Weinberger A; Halpern Z; Zelber-Sagi S; Elinav E; Segal E
BMC Med; 2022 Feb; 20(1):56. PubMed ID: 35135549
[TBL] [Abstract][Full Text] [Related]
19. A prospective randomized controlled trial of the effects of vitamin D supplementation on long-term glycemic control in type 2 diabetes mellitus of Korea.
Ryu OH; Lee S; Yu J; Choi MG; Yoo HJ; Mantero F
Endocr J; 2014; 61(2):167-76. PubMed ID: 24240575
[TBL] [Abstract][Full Text] [Related]
20. Pharmacology and tolerability of a single dose of exenatide in adolescent patients with type 2 diabetes mellitus being treated with metformin: a randomized, placebo-controlled, single-blind, dose-escalation, crossover study.
Malloy J; Capparelli E; Gottschalk M; Guan X; Kothare P; Fineman M
Clin Ther; 2009 Apr; 31(4):806-15. PubMed ID: 19446153
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
